Completed NA INTERVENTIONAL 1-arm NCT02719821

Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation

Sponsor: National Cancer Institute (NCI)

Conditions Hodgkin's Lymphoma Leukemia Lymphoid Leukemia Multiple Myeloma Myelodysplastic Syndrome Myeloid Leukemia Non-hodgkin's Lymphoma

Interventions Behavioral techniques

Updated 7 times since 2017 Last updated: Nov 14, 2019 Started: Mar 31, 2016 Primary completion: Jun 2, 2017 Completion: Jun 2, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hodgkin's Lymphoma and Leukemia and is currently completed. National Cancer Institute (NCI) leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA
Mar 2019 — Dec 2019 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Active Not Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Wisconsin, Madison

Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madison, United States